146 related articles for article (PubMed ID: 38161574)
1. Enhancing Our Understanding of Cell Types, Differentiation, and Disease Through Enhancers: An Interview with César Daniel Meléndez-Ramírez, MS.
Abu-Shamma R
Yale J Biol Med; 2023 Dec; 96(4):569-572. PubMed ID: 38161574
[No Abstract] [Full Text] [Related]
2. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
[TBL] [Abstract][Full Text] [Related]
3. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease.
Venkatesh K; Sen D
Curr Stem Cell Res Ther; 2017; 12(4):326-347. PubMed ID: 27842480
[TBL] [Abstract][Full Text] [Related]
5. Proliferation and Differentiation of Dopaminergic Neurons from Human Neuroepithelial Stem Cells Obtained from Embryo Reduction Following In Vitro Fertilization.
Binh NT; Son NK; Phuong DT; Huong DT; Hoan NP; Hoa NT; Duc NM; Ha NM
Med Arch; 2021 Aug; 75(4):280-285. PubMed ID: 34759448
[TBL] [Abstract][Full Text] [Related]
6. Induced dopaminergic neurons: A new promise for Parkinson's disease.
Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
[TBL] [Abstract][Full Text] [Related]
7. Enhanced differentiation of human dopaminergic neuronal cell model for preclinical translational research in Parkinson's disease.
Harischandra DS; Rokad D; Ghaisas S; Verma S; Robertson A; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165533. PubMed ID: 31442530
[TBL] [Abstract][Full Text] [Related]
8. Stem cell therapy for Parkinson's disease.
Takahashi J
Ernst Schering Res Found Workshop; 2006; (60):229-44. PubMed ID: 16903426
[TBL] [Abstract][Full Text] [Related]
9. Stem cells in the treatment of Parkinson's disease.
Arenas E
Brain Res Bull; 2002 Apr; 57(6):795-808. PubMed ID: 12031276
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons.
Rössler R; Boddeke E; Copray S
Neuroscience; 2010 Oct; 170(2):417-28. PubMed ID: 20643196
[TBL] [Abstract][Full Text] [Related]
11. PCL/gelatin scaffolds and beta-boswellic acid synergistically increase the efficiency of CGR8 stem cells differentiation into dopaminergic neuron: A new paradigm of Parkinson's disease cell therapy.
Kheradmand H; Babaloo H; Vojgani Y; Mirzakhanlouei S; Bayat N
J Biomed Mater Res A; 2021 Apr; 109(4):562-571. PubMed ID: 32588502
[TBL] [Abstract][Full Text] [Related]
12. Stem cell-based therapy for Parkinson's disease.
Correia AS; Anisimov SV; Li JY; Brundin P
Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
[TBL] [Abstract][Full Text] [Related]
13. Synthetic mRNA-based differentiation method enables early detection of Parkinson's phenotypes in neurons derived from Gaucher disease-induced pluripotent stem cells.
Akiyama T; Sato S; Ko SBH; Sano O; Sato S; Saito M; Nagai H; Ko MSH; Iwata H
Stem Cells Transl Med; 2021 Apr; 10(4):572-581. PubMed ID: 33342090
[TBL] [Abstract][Full Text] [Related]
14. Roles of FGF20 in dopaminergic neurons and Parkinson's disease.
Itoh N; Ohta H
Front Mol Neurosci; 2013; 6():15. PubMed ID: 23754977
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of Midbrain Dopaminergic Neurons from Human iPS Cells.
Ishikawa KI; Nonaka R; Akamatsu W
Methods Mol Biol; 2021; 2322():73-80. PubMed ID: 34043194
[TBL] [Abstract][Full Text] [Related]
16. Early specification of dopaminergic phenotype during ES cell differentiation.
Parmar M; Li M
BMC Dev Biol; 2007 Jul; 7():86. PubMed ID: 17640353
[TBL] [Abstract][Full Text] [Related]
17. Role of transcription factors in cell replacement therapies for neurodegenerative conditions.
Thomas M
Regen Med; 2010 May; 5(3):441-50. PubMed ID: 20455654
[TBL] [Abstract][Full Text] [Related]
18. "NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells.
Anisimov SV; Christophersen NS; Correia AS; Li JY; Brundin P
BMC Genomics; 2007 Feb; 8():46. PubMed ID: 17288595
[TBL] [Abstract][Full Text] [Related]
19. Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells.
Grow DA; Simmons DV; Gomez JA; Wanat MJ; McCarrey JR; Paladini CA; Navara CS
Stem Cells Transl Med; 2016 Sep; 5(9):1133-44. PubMed ID: 27343168
[TBL] [Abstract][Full Text] [Related]
20. Nonhypoxic pharmacological stabilization of Hypoxia Inducible Factor 1α: Effects on dopaminergic differentiation of human neural stem cells.
Hey SM; Jensen P; Ryding M; Martínez Serrano A; Kristensen BW; Meyer M
Eur J Neurosci; 2019 Feb; 49(4):497-509. PubMed ID: 30471165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
